Company

Transcend Therapeutics

Biotechnology Research 220 5th Ave 25 employees

Employees: 25
Contacts: 1
Emails: 1

www.transcendtherapeutics.com LinkedIn Crunchbase

Transcend Therapeutics Overview

Headquarters: 220 5th Ave
Website: www.transcendtherapeutics.com
Industry: Biotechnology Research
Employees: 25
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Transcend Therapeutics

Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation. As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.

Transcend Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Transcend Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
David Fife	Managing Partner at Integrated Vc		View
Jennifer Schmidt	VP, Scientific Affairs at Transcend		View
Blake Mandell	Co-founder and CEO, Transcend	New York, United States	Email
Rosalynn Landazuri	Clinical Research Associate		View